The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Open accessAbstract
Loss of Hippo signaling in Drosophila leads to tissue overgrowth as a result of increased cell proliferation and decreased cell death. YAP (a homolog of Drosophila Yorkie and target of the Hippo pathway) was recently implicated in control of organ size, epithelial tissue development, and tumorigenesis in mammals. However, the role of the mammalian Hippo pathway in such regulation has remained unclear. We now show that mice with liver-specific ablation of WW45 (a homolog of Drosophila Salvador and adaptor for the Hippo kinase) manifest increased liver size and expansion of hepatic progenitor cells (oval cells) and eventually develop hepatomas. Moreover, ablation of WW45 increased the abundance of YAP and induced its localization to the nucleus in oval cells, likely accounting for their increased proliferative capacity, but not in hepatocytes. Liver tumors that developed in mice heterozygous for WW45 deletion or with liver-specific WW45 ablation showed a mixed pathology combining characteristics of hepatocellular carcinoma and cholangiocarcinoma and seemed to originate from oval cells. Together, our results suggest that the mammalian Hippo–Salvador pathway restricts the proliferation of hepatic oval cells and thereby controls liver size and prevents the development of oval cell–derived tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Liver regeneration: from myth to mechanism
Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567 · cited 1×
“After partial hepatectomy, the healthy liver regenerates solely through hepatocyte proliferation (25).”
BackgroundYAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Self-citationMYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M. J., Lee, J.-S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721
Self-citationThe role of hepatocytes and oval cells in liver regeneration and repopulation
Fausto, N., & Campbell, J. S. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00338-6 · Cited by 648
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila
Pantalacci, S., Tapon, N., & Léopold, P. (2003) · Nature Cell Biology · doi:10.1038/ncb1051 · Cited by 551
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction
St John, M. A. R., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M. L., Brownstein, D. G., Parlow, A. F., McGrath, J., & Xu, T. (1999) · Nature Genetics · doi:10.1038/5965 · Cited by 439
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
Morin-Kensicki, E. M., Boone, B. N., Howell, M., Stonebraker, J. R., Teed, J., Alb, J. G., Magnuson, T. R., O'Neal, W., & Milgram, S. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.77-87.2006 · Cited by 429
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
Roskams, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209558 · Cited by 422
TWEAK induces liver progenitor cell proliferation
Jakubowski, A., Ambrose, C., Parr, M., Lincecum, J. M., Wang, M. Z., Zheng, T. S., Browning, B., Michaelson, J. S., Baestcher, M., Wang, B., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23486 · Cited by 419
The origin and liver repopulating capacity of murine oval cells
Wang, X., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., & Grompe, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734199100 · Cited by 410
Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
Oka, T., Mazack, V., & Sudol, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804380200 · Cited by 367
Jeong, W.-I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.007 · Cited by 310
Self-citationEvidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.
Sell, S., & Dunsford, H. A. (1989) · Europe PMC (PubMed Central) · Cited by 290
Wallace, K., Burt, A. D., & Wright, M. C. (2008) · Biochemical Journal · doi:10.1042/bj20071570 · Cited by 262
Zhang, J., Smolen, G. A., & Haber, D. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6205 · Cited by 243
Mouse A6-Positive Hepatic Oval Cells Also Express Several Hematopoietic Stem Cell Markers
Petersen, B. E., Grossbard, B., Hatch, H., Pi, L., Deng, J., & Scott, E. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50104 · Cited by 235
Dumble, M. L., Croager, E. J., Yeoh, G. C. T., & Quail, E. A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.435 · Cited by 222
Primary liver carcinoma of intermediate (hepatocyte–cholangiocyte) phenotype
Kim, H., Park, C., Han, K.-H., Choi, J., Kim, Y. B., Kim, J. K., & Park, Y. N. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.023 · Cited by 212
Self-citationHepatic ‘stem cell’ malignancies in adults: four cases
Theise, N. D., Yao, J. L., Harada, K., Hytiroglou, P., Portmann, B., Thung, S. N., Tsui, W., Ohta, H., & Nakanuma, Y. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01707.x · Cited by 207
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
Sell, S. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s515 · Cited by 201
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity
McPherson, J. P., Tamblyn, L., Elia, A., Migon, E., Shehabeldin, A., Matysiak‐Zablocki, E., Lemmers, B., Salmena, L., Hakem, A., Fish, J., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600371 · Cited by 201
Preisegger, K., Factor, V. M., Fuchsbichler, A., Stumptner, C., Denk, H., & Thorgeirsson, S. S. (1999) · PubMed · Cited by 194
A crucial role of WW45 in developing epithelial tissues in the mouse
Lee, J., Kim, T., Yang, T., Koo, B., Oh, S., Lee, K., Oh, H., Lee, S., Kong, Y., Kim, J., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.63 · Cited by 194
Self-citationLiver Stem Cells and Prospects for Liver Reconstitution by Transplanted Cells
Shafritz, D. A., Oertel, M., Menthena, A., Nierhoff, D., & Dabeva, M. D. (2006) · Hepatology · doi:10.1002/hep.21047 · Cited by 145
Crucial Role for Mst1 and Mst2 Kinases in Early Embryonic Development of the Mouse
Oh, S., Lee, D., Kim, T., Kim, T., Oh, H. J., Hwang, C. Y., Kong, Y., Kwon, K., & Lim, D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00551-09 · Cited by 145
Self-citationDose‐ and time‐dependent oval cell reaction in acetaminophen‐induced murine liver injury†
Kofman, A. V., Morgan, G., Kirschenbaum, A., Osbeck, J., Hussain, M. A., Swenson, S. E., & Theise, N. D. (2005) · Hepatology · doi:10.1002/hep.20696 · Cited by 123
Liver stem cells: A scientific and clinical perspective
Dan, Y. Y., & Yeoh, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05383.x · Cited by 98
Robrechts, C., Vos, R. D., den Heuvel, M. V., Cutsem, E. V., Damme, B. V., Desmet, V. J., & Roskams, T. (1998) · Liver International · doi:10.1111/j.1600-0676.1998.tb00168.x · Cited by 82
Origin of hepatocellular carcinoma: Role of stem cells
Wu, X., & Chen, D. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04485.x · Cited by 63
Engelhardt, N. V., Factor, V. M., Medvinskiĭ, A. L., Baranov, V. N., Lazareva, M. N., & Poltoranina, V. S. (1993) · Differentiation · doi:10.1111/j.1432-0436.1993.tb00029.x · Cited by 51
Oval cells — hepatocytes relationships in Dipin-induced hepatocarcinogenesis in mice
Factor, V. M., & Sa, R. (1993) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80399-4 · Cited by 34
del Castillo, G., Factor, V. M., Fernández, M., Alvarez, A. M., Fabregat, I., Thorgeirsson, S. S., & Sánchez, A. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070793 · Cited by 34
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Metadata
- Authors
- Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D. F., Kim, J.-M., & Lim, D.-S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-04-19
- Volume
- 107
- Issue
- 18
- Pages
- 8248-8253
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2067592231
- Cited by
- 493
- References
- 43
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.